Xiaozhao Lu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA Research and Splicing
- Extracellular vesicles in disease
Papers in
-
- Cardiovascular Function and Risk Factors 4
- Cardiac Fibrosis and Remodeling 3
- Heart Failure Treatment and Management 2
-
- Acute Kidney Injury Research 3
- Co-authors
- Guodong Yang (13 shared papers)Lijun Yuan (2 shared papers)Zifan Lu (9 shared papers)Haiyan Fu (8 shared papers)Mengying Wei (8 shared papers)Jun Pu (3 shared papers)Liang Jin (4 shared papers)Huanyu Lu (4 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)Reviews in Cardiovascular Medicine (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Cardiovascular Diabetology (2 papers)Cancer Biology & Therapy (2 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Xiaozhao Lu
37 papers receiving 1.6k citations
Xiaozhao Lu's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 859
- Molecular Biology 344
- Nephrology 50
- Cardiology and Cardiovascular Medicine 115
- Endocrinology, Diabetes and Metabolism 70
Countries citing papers authored by Xiaozhao Lu
This map shows the geographic impact of Xiaozhao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhao Lu more than expected).
Fields of papers citing papers by Xiaozhao Lu
This network shows the impact of papers produced by Xiaozhao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhao Lu. The network helps show where Xiaozhao Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaozhao Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | LncRNA: A link between RNA and cancer Hit paper breakdown → | 2014 | 837 |
| 2 | 2009 | 116 | |
| 3 | 2013 | 81 | |
| 4 | 2012 | 62 | |
| 5 | 2012 | 53 | |
| 6 | 2013 | 52 | |
| 7 | 2015 | 43 | |
| 8 | 2022 | 36 | |
| 9 | 2017 | 32 | |
| 10 | 2012 | 31 | |
| 11 | 2017 | 28 | |
| 12 | 2014 | 26 | |
| 13 | 2016 | 26 | |
| 14 | 2011 | 25 | |
| 15 | 2018 | 24 | |
| 16 | 2013 | 19 | |
| 17 | 2022 | 17 | |
| 18 | 2023 | 17 | |
| 19 | 2025 | 15 | |
| 20 | 2015 | 13 |
About Xiaozhao Lu
Xiaozhao Lu is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Endocrinology, Diabetes and Metabolism, Oncology and Cancer Research, having authored 39 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Cells and Metastasis (3 papers), Acute Kidney Injury Research (3 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Cardiac Fibrosis and Remodeling (3 papers), Heart Failure Treatment and Management (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Cancer Research (859 citations), Molecular Biology (344 citations), Nephrology (50 citations), Cardiology and Cardiovascular Medicine (115 citations) and Endocrinology, Diabetes and Metabolism (70 citations). Xiaozhao Lu has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Guodong Yang, Lijun Yuan, Zifan Lu, Haiyan Fu, Mengying Wei, Jun Pu, Liang Jin, Huanyu Lu, Libo Yao and Yue Feng. Their work appears in journals such as Biochemical and Biophysical Research Communications, Reviews in Cardiovascular Medicine, Frontiers in Cardiovascular Medicine, Cardiovascular Diabetology and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.